Human Papillomavirus Vaccination After COVID-19.
Zheng Quan Toh, Fiona M Russell, Suzanne M Garland, Edward K Mulholland, George Patton, Paul V Licciardi
JNCI Cancer Spectrum | Published : 2021
The current global novel coronavirus disease 2019 (COVID-19) pandemic threatens to derail the uptake of human papillomavirus (HPV) vaccination in low- and lower-middle income countries with major disruptions to routine immunization and the introduction of new vaccines delayed. This has a major impact on the World Health Organization cervical cancer elimination strategy, where it is dependent on HPV vaccination as well as cervical cancer screening and treatment. We discuss current opportunities and barriers to achieve high uptake of HPV vaccination in low- and lower-middle income countries as well as the impact of COVID-19. Implementation of 4 key recommendations for HPV vaccination in low- a..View full abstract